BioCentury
ARTICLE | Clinical News

Agennix Inc. regulatory update

March 8, 1999 8:00 AM UTC

Agennix received Indian Patent No. 177,650 covering the production of recombinant human lactoferrin, a protein that regulates tumor necrosis factor alpha, and lactoferrin polypeptides, including ferm...